MODERN CHI MED obtains Stock Exchange waiver, extends major-transaction circular deadline to 30 June 2026

Bulletin Express
05/07

Modern Chinese Medicine Group Co., Ltd. (MODERN CHI MED) has secured a further waiver from the Hong Kong Stock Exchange regarding Rule 14.41(a) of the Listing Rules, allowing additional time to dispatch its major-transaction circular.

The circular, covering details of the share-purchase agreement, audited financial statements of the target group for the three years ended 31 December 2025, and pro forma financial information of the enlarged group, was originally due on or before 30 April 2026. The revised deadline is now on or before 30 June 2026.

The Stock Exchange granted the waiver on 6 May 2026. The regulator reserves the right to withdraw or amend the waiver should circumstances change.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10